{"disease":{"id":"dna-repair-disorder","name":"dna repair disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02912559","title":"Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":712,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05484570","title":"Natural History Study for DNA Repair Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT04232085","title":"Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT03236935","title":"Phase Ib of L-NMMA and Pembrolizumab","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}